GRMN stock · PMN stock

GRMN vs PMN · P/E 28, rev $7.25B vs P/E 4.8, $14.1M cap

Garmin Ltd (GRMN) versus ProMIS Neurosciences Inc. (PMN) — a side-by-side from cached financials, not a winner call.

Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.

ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.

Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.

PMN does not have a complete income-statement cache yet.

GRMN currently screens at market cap $41.35B and trailing P/E 28.3. PMN currently screens at market cap $14.1M and trailing P/E 4.8.

Not investment advice. Open the GRMN and PMN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons